Adrenomedullin increases fibroblast-like synoviocyte adhesion to extracellular matrix proteins by upregulating integrin activation

Arthritis Research and Therapy

Volumn 12, Issue 5, 2010, Pages

  Ah Kioon, Marie Dominique ^a,b   Asensio, Carine ^a,b   Ea, Hang Korng ^a,b,c   Uzan, Benjamin ^a,b   Cohen Solal, Martine ^a,b,c   Lioté, Frédéric ^a,b,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UFR Faculty of Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ALPHA2 INTEGRIN; BETA1 INTEGRIN; COLLAGEN TYPE 1; FIBRONECTIN; INTEGRIN; MATRIX PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; SMALL INTERFERING RNA; TALIN; VITRONECTIN; ADM PROTEIN, HUMAN; SCLEROPROTEIN;

ARTICLE; BONE MATRIX; CARTILAGE MATRIX; CELL ADHESION; CELL ISOLATION; CLINICAL ARTICLE; DENSITOMETRY; EXTRACELLULAR MATRIX; FIBROBLAST; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION; WESTERN BLOTTING; CYTOLOGY; FLUORESCENCE MICROSCOPY; METABOLISM; SYNOVIUM;

ADRENOMEDULLIN; BLOTTING, WESTERN; CELL ADHESION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; IMMUNOPRECIPITATION; INTEGRINS; MICROSCOPY, FLUORESCENCE; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 77957761071     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3160     Document Type: Article

References (38)

1. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000, 2:361-367. 10.1186/ar113, 130137, 11094449.
2. Wang AZ, Wang JC, Fisher GW, Diamond HS. Interleukin-1beta-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arthritis Rheum 1997, 40:1298-1307.
3. Mould AP, Humphries MJ. Regulation of integrin function through conformational complexity: not simply a knee-jerk reaction?. Curr Opin Cell Biol 2004, 16:544-551. 10.1016/j.ceb.2004.07.003, 15363805.
4. Calderwood DA, Tai V, Di Paolo G, De Camilli P, Ginsberg MH. Competition for talin results in trans-dominant inhibition of integrin activation. J Biol Chem 2004, 279:28889-28895. 10.1074/jbc.M402161200, 15143061.
5. Moser M, Legate KR, Zent R, Fassler R. The tail of integrins, talin, and kindlins. Science 2009, 324:895-899. 10.1126/science.1163865, 19443776.
6. Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol 2005, 17:509-516. 10.1016/j.ceb.2005.08.010, 16099636.
7. Rinaldi N, Schwarz-Eywill M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, Barth TF. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis 1997, 56:45-51. 10.1136/ard.56.1.45, 1752256, 9059141.
8. Beltowski J, Jamroz A. Adrenomedullin: what do we know 10 years since its discovery?. Pol J Pharmacol 2004, 56:5-27.
9. Naot D, Cornish J. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone 2008, 43:813-818. 10.1016/j.bone.2008.07.003, 18687416.
10. Uzan B, Ea HK, Launay JM, Garel JM, Champy R, Cressent M, Liote F. A critical role for adrenomedullin-calcitonin receptor-like receptor in regulating rheumatoid fibroblast-like synoviocyte apoptosis. J Immunol 2006, 176:5548-5558.
11. Yudoh K, Matsuno H, Kimura T. Plasma adrenomedullin in rheumatoid arthritis compared with other rheumatic diseases. Arthritis Rheum 1999, 42:1297-1298. 10.1002/1529-0131(199906)42:6<1297::AID-ANR30>3.0.CO;2-J, 10366127.
12. Chosa E, Hamada H, Kitamura K, Eto T, Tajima N. Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis. J Rheumatol 2003, 30:2553-2556.
13. Zudaire E, Martinez A, Cuttitta F. Adrenomedullin and cancer. Regul Pept 2003, 112:175-183. 10.1016/S0167-0115(03)00037-5, 12667640.
14. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 1995, 77:660-664.
15. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, So JN, Park SK. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 2003, 17:1937-1939.
16. Nikitenko LL, Fox SB, Kehoe S, Rees MC, Bicknell R. Adrenomedullin and tumour angiogenesis. Br J Cancer 2006, 94:1-7. 10.1038/sj.bjc.6602832, 2361077, 16251875.
17. Hagi-Pavli E, Farthing PM, Kapas S. Stimulation of adhesion molecule expression in human endothelial cells (HUVEC) by adrenomedullin and corticotrophin. Am J Physiol Cell Physiol 2004, 286:C239-C246. 10.1152/ajpcell.00036.2003, 14534081.
18. Hagi-Pavli E, Farthing PM, Henshaw FN, Kapas S. Presentation of ICAM-1 protein at the cell surface of oral keratinocytes in the presence of adrenomedullin and corticotrophin. Cell Physiol Biochem 2005, 15:167-174. 10.1159/000083649, 15665526.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
20. Liote F, Champy R, Moenner M, Boval-Boizard B, Badet J. Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol 2003, 132:163-168. 10.1046/j.1365-2249.2003.02117.x, 1808677, 12653852.
21. Luque A, Gomez M, Puzon W, Takada Y, Sanchez-Madrid F, Cabanas C. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem 1996, 271:11067-11075. 10.1074/jbc.271.19.11067, 8626649.
22. Bazzoni G, Hemler ME. Are changes in integrin affinity and conformation overemphasized?. Trends Biochem Sci 1998, 23:30-34. 10.1016/S0968-0004(97)01141-9, 9478133.
23. Haynes BF, Hale LP, Patton KL, Martin ME, McCallum RM. Measurement of an adhesion molecule as an indicator of inflammatory disease activity: up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum 1991, 34:1434-1443. 10.1002/art.1780341115, 1719988.
24. Scott DL, Wainwright AC, Walton KW, Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis 1981, 40:142-153. 10.1136/ard.40.2.142, 1000696, 7013719.
25. Vartio T, Vaheri A, Von Essen R, Isomaki H, Stenman S. Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest 1981, 11:207-212. 10.1111/j.1365-2362.1981.tb01842.x, 6791940.
26. Nikkari L, Haapasalmi K, Aho H, Torvinen A, Sheppard D, Larjava H, Heino J. Localization of the alpha v subfamily of integrins and their putative ligands in synovial lining cell layer. J Rheumatol 1995, 22:16-23.
27. Nikkari L, Aho H, Yli-Jama T, Larjava H, Jalkanen M, Heino J. Expression of integrin family of cell adhesion receptors in rheumatoid synovium: alpha 6 integrin subunit in normal and hyperplastic synovial lining cell layer. Am J Pathol 1993, 142:1019-1027. 1886885, 7682757.
28. Ishikawa H, Hirata S, Nishibayashi Y, Imura S, Kubo H, Ohno O. The role of adhesion molecules in synovial pannus formation in rheumatoid arthritis. Clin Orthop Relat Res 1994, 297-303.
29. Deftos LJ. Bone protein and peptide assays in the diagnosis and management of skeletal disease. Clin Chem 1991, 37:1143-1148.
30. Schett G. Cells of the synovium in rheumatoid arthritis: osteoclasts. Arthritis Res Ther 2007, 9:203. 10.1186/ar2110, 1860063, 17316459.
31. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:669-675. 10.1093/rheumatology/kel065, 16567358.
32. Schedel J, Wenglen C, Distler O, Muller-Ladner U, Scholmerich J, Heinegard D, Krenn V. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis. Scand J Immunol 2004, 60:514-523. 10.1111/j.0300-9475.2004.01507.x, 15541045.
33. Howe AK. Regulation of actin-based cell migration by cAMP/PKA. Biochim Biophys Acta 2004, 1692:159-174.
34. Iimuro S, Shindo T, Moriyama N, Amaki T, Niu P, Takeda N, Iwata H, Zhang Y, Ebihara A, Nagai R. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res 2004, 95:415-423. 10.1161/01.RES.0000138018.61065.d1, 15242974.
35. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L, Boudouresque F. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int J Cancer 2004, 108:797-804. 10.1002/ijc.11663, 14712479.
36. Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Menard JF, Pouplin S, Boumier P, Vittecoq O, Le Loet X, Boissier MC. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 2007, 124:158-164. 10.1016/j.clim.2007.04.014, 17560831.
37. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brunner N, Martin PM. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002, 160:1279-1292. 1867212, 11943713.
38. Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, Kobayashi T, Shindo M, Higashino F, Katoh H, Asaka M, Kondo T, Hosokawa M, Kobayashi M. Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 2003, 22:1238-1242. 10.1038/sj.onc.1206207, 12606950.